Application of ctDNA in Evaluation of Neoadjuvant Chemotherapy Efficacy and Exploration of Chemoresistance Mechanisms in Pancreatic Cancer

Clinical trial NCT05848154 · UNKNOWN

Trial details

NCT number: NCT05848154
Sponsor: Shanghai Zhongshan Hospital
Status: UNKNOWN
Study type: OBSERVATIONAL

Patients With Non-metastatic Pancreatic Cancer Evaluation of Tumor Resectability Shall be Made in Consensus at Multidisciplinary Meetings, According to NCCN Guideline Version 1.2022 Pancreatic Adenocarcinoma

Start date: 2023-06-01
Primary completion: 2026-01-31
Enrollment: 92

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.